株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のアプタマー市場 - 成長、傾向、および予測(2019年 - 2024年)

Aptamers Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 391436
出版日 ページ情報 英文 110 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.78円で換算しております。
Back to Top
世界のアプタマー市場 - 成長、傾向、および予測(2019年 - 2024年) Aptamers Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年03月01日 ページ情報: 英文 110 Pages
概要

世界のアプタマー市場は2019年から2024年の間に17.8%のCAGRで成長すると予測されています。アプタマー開発技術の進歩、研究開発費の増加、この市場への投資企業の増加等が、当市場の成長を支える重要な要因に挙げられます。

当レポートでは世界のアプタマー市場について調査しており、市場の機会および動向、成長および阻害要因、タイプ・用途・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

  • 研究の成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場成長要因
  • 市場阻害要因
  • ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界内の競争

第5章 市場セグメント

  • タイプ別
    • 核酸
    • ペプチド
  • 用途別
    • 診断
    • 治療学
    • 研究開発
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東およびアフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • AM Biotechnologies, LLC
    • Aptagen, LLC
    • Aptamer Sciences, Inc.
    • Aptamer Group
    • Aptus Biotech S.L.
    • Base Pair Biotechnologies, Inc.
    • NOXXON Pharma
    • SomaLogic Inc.
    • TriLink BioTechnologies, Inc.
    • Vivonics, Inc.

第7章 市場機会および将来動向

目次
Product Code: 46393

Market Overview

The global aptamers market is expected to witness a CAGR of 17.8% during the forecast period. Advancements in aptamer development technologies, increasing R&D expenditure, and the rising number of companies investing in this market are some of the key driving factors responsible for the growth of this market. Numerous advantages offered by these small molecules, in comparison to established antibodies, have also led to higher demand for these molecules across a diverse range of medical applications. They are chemically synthesized, which eliminates batch-to-batch variation and demands less time for development. Along with this, continuous advancement in technologies is expected to stimulate growth.

However, many aptamers have failed to meet the requisite safety and efficacy standards in clinical studies. Thus, companies have to terminate their clinical investigation during late-stage clinical studies. This factor is likely to affect the growth of this market negatively. In addition, other factors, such as low awareness about these technologies in middle- and low-income countries and inadequate regulatory structure, may hamper the overall growth.

Scope of the Report

Aptamers are short, single-stranded DNA or RNA (ssDNA or ssRNA) molecules, which can selectively bind to a specific target, including peptides, proteins, small molecules, carbohydrates, toxins, and even live cells. Aptamers assume various shapes, owing to their tendency to form helices or single-stranded loops. These molecules are extremely versatile and are used to bind targets with high specificity and selectivity.

Key Market Trends

Diagnostics is expected to hold a Significant Market Share in the Application Type Segmentation

Appropriate diagnosis is the most crucial factor for the treatment of diseases, especially the viral ones. Over the past few years, aptamer technology has observed a significant rise in its demand and usage all across the world. It has been used in a wide range of diagnostic as well as therapeutic applications; several strategies are currently being explored, in a definitive or conclusive way, using aptamers against virus proteins. From a diagnostic point of view, aptamers are presently being designed as a bio-recognition element in a variety of diagnostic systems in order to detect viral proteins, either in the blood (serum or plasma) or in the infected cells.

North America dominates the Market and expected to do the Same in the Forecast Period

By geography, the aptamers market is segmented into North America, Europe, Asia-Pacific, the Middle East & Africa, and South America. North America dominates the aptamers market due to rapid technological advancements and high investment and funding to support the development of aptamers. Asia-Pacific is also expected to propel the global aptamers market, owing to factors, such as increasing research & development activities and economic growth.

Competitive Landscape

The global aptamers market is highly competitive and consists of a number of major players. Companies, like AM Biotechnologies, LLC, Aptagen, LLC, Aptamer Sciences, Inc., Aptamer Group, Aptus Biotech S.L., Base Pair Biotechnologies, Inc., NOXXON Pharma, SomaLogic Inc., TriLink BioTechnologies, Inc., and Vivonics, Inc., among others, hold the substantial share in the aptamers market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Advantage of Aptamers Compared to Antibodies
    • 4.2.2 Advancements in the Field of Aptamer Development Technologies
    • 4.2.3 Growing Investment by Major Companies
  • 4.3 Market Restraints
    • 4.3.1 Rising Number of Setbacks of Aptamer Therapeutics in Late Stage Clinical Studies
    • 4.3.2 Low Awareness Level and Incomplete Regulatory Policies
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Type
    • 5.1.1 Nucleic Acid
    • 5.1.2 Peptide
  • 5.2 Application
    • 5.2.1 Diagnostics
    • 5.2.2 Therapeutics
    • 5.2.3 Research and Development
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AM Biotechnologies, LLC
    • 6.1.2 Aptagen, LLC
    • 6.1.3 Aptamer Sciences, Inc.
    • 6.1.4 Aptamer Group
    • 6.1.5 Aptus Biotech S.L.
    • 6.1.6 Base Pair Biotechnologies, Inc.
    • 6.1.7 NOXXON Pharma
    • 6.1.8 SomaLogic Inc.
    • 6.1.9 TriLink BioTechnologies, Inc.
    • 6.1.10 Vivonics, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top